share_log

泰恩康(301263.SZ)：创新药管线有治疗白癜风的CKBA软膏，现正在开展II期临床研究

Tienkang (301263.SZ): There is an innovative drug pipeline with CKBA ointment for treating vitiligo, which is currently undergoing phase II clinical research.

Gelonghui Finance ·  Aug 7 04:34

On August 7th, Gelonhui reported that Tienkang (301263.SZ) announced on the investor interaction platform that the company's innovative drug pipeline includes CKBA ointment for the treatment of vitiligo, which is currently undergoing Phase II clinical trials. In July of this year, the executive meeting of the State Council passed the "Implementation Plan for Supporting the Entire Chain's Development of Innovative Drugs", which pointed out that it is necessary to strengthen policy guarantees throughout the chain, coordinate the use of policies such as price management, medical insurance payment, commercial insurance, drug supply and use, investment and financing, optimize the evaluation and review mechanism and medical institution assessment mechanism, and jointly promote the breakthrough and development of innovative drugs. It is necessary to mobilize various scientific and technological innovation resources, strengthen basic research on new drug development, and consolidate the foundation of China's innovative drug development. The passage of this plan is expected to further stimulate the innovation vitality of the industry, and the company will also actively advance project progress steadily in accordance with the policy.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment